Cited by 117COVID-19 and Mental HealthLong-Term Effects of COVID-19COVID-19 Clinical Research Studies

The effects of disease severity, use of corticosteroids and social factors on neuropsychiatric complaints in severe acute respiratory syndrome (SARS) patients at acute and convalescent phases

Open access
Sheng, Bun, Wing Cheng, Sammy Kin, Lau, Kwok Kwong, Li, Ho Lun, Yiu Chan, Eric Lok·2005·European Psychiatry

Abstract

Objective: To evaluate the effects of disease severity, corticosteroids and social factors on neuropsychiatric complaints in severe acute respiratory syndrome (SARS) patients, both during acute and convalescent phases. Methods: Self-administered mail questionnaires survey to 308 SARS patients after discharging from hospital. Both patients and their families were asked about symptoms related to various neuropsychiatric domains, and the questions covered both acute and convalescent phases. Results: Among the 102 (33%) valid replies, 65% had strong symptoms in convalescent phase as indicated by GHQ28 score ≥ 5. In multiple linear regression analysis, use of pulse steroid and total dosages of pulse steroid during hospitalisation were predictive for anxiety-depression, psychosis and behavioural symptoms in acute phase, the effects persisted in convalescent phase. Disease severity had direct correlation with symptoms in all neuropsychiatric domains at acute phase and anxiety-depression and cognition at convalescent phase. Health care workers had more neuropsychiatric complaints in both phases. Severity of symptoms, corticosteroids and social factors explained about half of the variances (R2 = 52) in anxiety-depression at acute phase and 33% at convalescent phase. Conclusions: Severe disease, high dose corticosteroids and being health care workers were independent predictors of neuropsychiatric complaints in both acute and convalescent phases.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.eurpsy.2004.06.023

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The present findings parallel those of earlier coronavirus outbreak studies, in which post-illness psychiatric morbidity ranged from 10% to 35%.

    “Our findings mirror the results from previous coronaviruses outbreak studies, where the psychiatric morbidities ranged from 10% to 35% in the post-illness stage (Rogers et al., 2020, Sheng et al., 2005).”
  • After recovery from SARS or MERS, more than 15% of patients showed deficits in memory, attention, concentration, or mental processing speed at follow-up periods of 6 weeks to 39 months.

    “In SARS and MERS, after recovery from the infection, impairment of memory, attention, concentration, or mental processing speed were reported in more than 15% of patients at a follow-up period ranging between 6 weeks and 39 months (Hopkins et al., 1999, Sheng et al., 2005).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Sheng, B., Wing Cheng, S. K., Lau, K. K., Li, H. L., & Yiu Chan, E. L.
Affiliations
Princess Margaret Hospital (HK)
Corresponding author
Sheng, Bun
Venue
European Psychiatry
Published
2005-05
Volume
20
Issue
3
Pages
236-242
ISSN
  • 0924-9338 (ISSN-L)
  • 1778-3585
OpenAlex
W1965607682
Cited by
117
References
28
Citations by year
2026: 1 · 2025: 4 · 2024: 4 · 2023: 9 · 2022: 22 · 2021: 27 · 2020: 36 · 2019: 1 · 2014: 1 · 2013: 1
FWCI
1.61
Type
journal article
Language
en
Open access
Locations
  • European Psychiatry (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Social Sciences › Psychology › Clinical Psychology › COVID-19 and Mental Health
  • Health Sciences › Medicine › Neurology › Long-Term Effects of COVID-19
  • Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
Keywords
SARS, neuropsychiatric symptoms, corticosteroids, disease severity, convalescence, anxiety and depression, psychosis, behavioural symptoms, cognitive impairment, healthcare workers, post-discharge outcomes, social factors
MeSH terms
Adult, Anti-Inflammatory Agents, Anxiety Disorders, Bipolar Disorder, Cognition Disorders, Convalescence, Demography, Factor Analysis, Statistical, Female, Health Personnel, Health Status, Humans, Male, Psychotic Disorders, Surveys and Questionnaires, Severity of Illness Index, Severe Acute Respiratory Syndrome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review